Skip to main content
Figure 6 | Journal of Translational Medicine

Figure 6

From: Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers

Figure 6

The combination treatment of gemcitabine with P276-00 showed significant tumor growth inhibition in PANC-1 xenograft model. (A) Differences in the Tumour weight (mg) in the different treatment groups. (B) Percent growth inhibition after treatment. Statistically significant difference (p < 0.005) of the combination treatment of gemcitabine and P276-00 compared with the control was seen.

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us